{
  "company": {
    "name": "CellCentric",
    "website": "https://cellcentric.com/",
    "record": "https://startuphistory.org/c/cellcentric.com"
  },
  "status": null,
  "history_since": "2008-04-19T02:57:25.000Z",
  "baseline": {
    "snapshot_id": "34c8187561d8ac82226c9be392472da3d686d71b4ab6258c2ca0a135285fe3b9",
    "observed_at": "2008-04-19T02:57:25.000Z",
    "headline": "CellCentric - Cellcentric prioritizes novel epigenetic targets and develops screens and hits",
    "description": null,
    "evidence": "https://web.archive.org/web/20080419025725/http://www.cellcentric.com:80/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T12:28:57.977Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2008-04-19T02:57:25.000Z",
      "variants": [
        {
          "headline": "CellCentric - Cellcentric prioritizes novel epigenetic targets and develops screens and hits",
          "subhead": null,
          "observed_at": "2008-04-19T02:57:25.000Z",
          "evidence": "https://web.archive.org/web/20080419025725/http://www.cellcentric.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "CellCentric - Cellcentric prioritizes novel epigenetic targets and develops screens and hits",
      "subhead": null,
      "from": "2008-04-19T02:57:25.000Z",
      "to": "2008-04-19T02:57:25.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20080419025725/http://www.cellcentric.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2008-04-19T02:57:25.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2010-08-18T23:06:02.000Z",
      "variants": [
        {
          "headline": "Unlocking Epigenetics",
          "subhead": "CellCentric has a dominant discovery platform in epigenetics",
          "observed_at": "2010-08-18T23:06:02.000Z",
          "evidence": "https://web.archive.org/web/20100818230602/http://www.cellcentric.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Unlocking Epigenetics",
      "subhead": "CellCentric has a dominant discovery platform in epigenetics",
      "from": "2010-08-18T23:06:02.000Z",
      "to": "2010-08-18T23:06:02.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20100818230602/http://www.cellcentric.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2010-08-18T23:06:02.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2014-02-18T00:20:29.000Z",
      "variants": [
        {
          "headline": "Focused Epigenetic Drug Discovery",
          "subhead": "CellCentric has a dominant discovery platform in epigenetics",
          "observed_at": "2012-09-25T12:24:29.000Z",
          "evidence": "https://web.archive.org/web/20120925122429/http://www.cellcentric.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Drug Discovery",
          "subhead": "CellCentric�s lead programme targets a deubiquitinase for cancer therapy.",
          "observed_at": "2014-02-18T00:20:29.000Z",
          "evidence": "https://web.archive.org/web/20140218002029/http://www.cellcentric.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Drug Discovery",
      "subhead": "CellCentric�s lead programme targets a deubiquitinase for cancer therapy.",
      "from": "2012-09-25T12:24:29.000Z",
      "to": "2014-02-18T00:20:29.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20140218002029/http://www.cellcentric.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2012-09-25T12:24:29.000Z",
          "to": "2014-02-18T00:20:29.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2021-01-21T21:30:18.000Z",
      "variants": [
        {
          "headline": "First-in-class p300/CBP inhibitor to treat specific cancers",
          "subhead": null,
          "observed_at": "2021-01-21T21:30:18.000Z",
          "evidence": "https://web.archive.org/web/20210121213018/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "First-in-class p300/CBP inhibitor to treat specific cancers",
      "subhead": null,
      "from": "2021-01-21T21:30:18.000Z",
      "to": "2021-01-21T21:30:18.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20210121213018/https://www.cellcentric.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2021-01-21T21:30:18.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2022-07-19T14:02:48.000Z",
      "variants": [
        {
          "headline": "We are developing inobrodib, a new drug to benefit people with cancer",
          "subhead": null,
          "observed_at": "2022-07-19T14:02:48.000Z",
          "evidence": "https://web.archive.org/web/20220719140248/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "We are developing inobrodib, a new drug to benefit people with cancer",
      "subhead": null,
      "from": "2022-07-19T14:02:48.000Z",
      "to": "2022-07-19T14:02:48.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20220719140248/https://www.cellcentric.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2022-07-19T14:02:48.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T12:28:57.977Z",
      "variants": [
        {
          "headline": "CellCentric – The p300/CBP inhibitor company",
          "subhead": null,
          "observed_at": "2025-11-03T16:09:26.000Z",
          "evidence": "https://web.archive.org/web/20251103160926/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CellCentric – The p300/CBP inhibitor company",
          "subhead": null,
          "observed_at": "2026-06-13T00:13:56.000Z",
          "evidence": "https://web.archive.org/web/20260613001356/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CellCentric – The p300/CBP inhibitor company",
          "subhead": null,
          "observed_at": "2026-10-07T19:19:39.000Z",
          "evidence": "https://web.archive.org/web/20261007191939/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CellCentric – The p300/CBP inhibitor company",
          "subhead": null,
          "observed_at": "2026-10-07T19:19:39.000Z",
          "evidence": "https://web.archive.org/web/20261007191939/https://www.cellcentric.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "CellCentric – The p300/CBP inhibitor company",
          "subhead": null,
          "observed_at": "2026-11-05T12:28:57.977Z",
          "evidence": "https://www.cellcentric.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "CellCentric – The p300/CBP inhibitor company",
      "subhead": null,
      "from": "2025-11-03T16:09:26.000Z",
      "to": "2026-11-05T12:28:57.977Z",
      "captures": 5,
      "evidence": "https://www.cellcentric.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-11-03T16:09:26.000Z",
          "to": "2026-11-05T12:28:57.977Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-f83ee5616264b60d4324993c457a777174678350da544ceee8efb27ad1df8247:cb16fd6d773318342bcfe353303a33a390e296022dcd54724073e67c2adf4817:headline:59731af251ef92af",
      "before_evidence": "https://web.archive.org/web/20100818230602/http://www.cellcentric.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Unlocking Epigenetics” to “Focused Epigenetic Drug Discovery”.",
      "between": {
        "from": "2010-08-18T23:06:02.000Z",
        "to": "2012-09-25T12:24:29.000Z"
      },
      "evidence": "https://web.archive.org/web/20120925122429/http://www.cellcentric.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-61430290d088350e9cf73318a548d66e95962816cb85b9b567103a968af5d07c:c8811c8a794b8c7a83d52cb273933393563173a9f8c1ff70889b3a8ce3f30f1a:funding:119fbec08b0f2014",
      "before_evidence": "https://web.archive.org/web/20140218002029/http://www.cellcentric.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “CellCentric secures funding to take its prostate cancer programme to IND.”.",
      "between": {
        "from": "2014-02-18T00:20:29.000Z",
        "to": "2016-07-16T12:19:01.000Z"
      },
      "evidence": "https://web.archive.org/web/20160716121901/http://www.cellcentric.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 3,
      "id": "page-5f92afd17782c0e92dd32370922d72e080a0d080a8a4ea6d8759d37e17cf3102:0531302fee54054dfec4b8754b1a734da3cc27d110d1a08dd564295dd17fbe95:headline:30c7f7dfbe15d90c",
      "before_evidence": "https://web.archive.org/web/20210121213018/https://www.cellcentric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “First-in-class p300/CBP inhibitor to treat specific cancers” to “We are developing inobrodib, a new drug to benefit people with cancer”.",
      "between": {
        "from": "2021-01-21T21:30:18.000Z",
        "to": "2022-07-19T14:02:48.000Z"
      },
      "evidence": "https://web.archive.org/web/20220719140248/https://www.cellcentric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 4,
      "id": "page-48ebf554fb2ba238f2c15b3ff9d993b911a49318d00c86f200153f0a627fa6d2:a5e49ea8332ae917022e4993ee078b7d36772228c905e8c4a16746561ec21c1b:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20251103160926/https://www.cellcentric.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2025-11-03T16:09:26.000Z",
        "to": "2026-06-13T00:13:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20260613001356/https://www.cellcentric.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “CellCentric” company record, https://startuphistory.org/c/cellcentric.com"
}